Treatment
Levonorgestrel clinical trials
We’re tracking 12 recruiting studies that include Levonorgestrel, each written for real people, not researchers, below.
Recruiting studies
- NCT07382583Recruiting
Study of a decision tool for endometrial cancer prevention
This study is developing a tool to help women decide if using a hormone-releasing intrauterine device (IUD) is right for them to lower their risk of endometrial cancer. Researchers are interviewing women at different risk levels and healthcare providers to make the tool useful and easy to understand.
Houston, TexasAges 18 years+ - NCT06162611RecruitingPhase 4
Emergency contraception with implant and pill
This study tests whether starting the birth control implant (Nexplanon) right after taking emergency contraceptive pills can be a safe and effective way to prevent pregnancy. You might qualify if you've had unprotected sex in the last 3 days and want a long-term birth control option.
Salt Lake City, UtahAges 18–35 - NCT06727734RecruitingPhase 3
Emergency contraception pill comparison study
This study compares two emergency contraception pills to see which works better. You take one pill after unprotected sex to help prevent pregnancy.
Hong KongAges 18–45 - NCT05444582RecruitingPhase 4
52 mg hormonal IUD placed for emergency or same-day birth control
This study checks whether placing a 52 mg hormonal IUD soon after sex (up to 5 days) or on the same day (under certain timing) is safe and works as birth control. You may be able to join if you need emergency contraception or want to start an IUD right away and meet clinic and pregnancy-safety checks.
San Jose, CaliforniaAges 16–35 - NCT06500390Recruiting
TMD and levonorgestrel IUD use study
This study looks at whether using a levonorgestrel intrauterine device (a hormone-releasing IUD) for at least 3 months is linked to jaw joint problems (temporomandibular disorder). It may help women understand potential side effects of this birth control method.
Istanbul, MaltepeAges 18–45 - NCT07759635Recruiting
Effects of Plan B on heart health in young women
This study looks at how the emergency contraceptive Plan B (levonorgestrel) affects heart and blood vessel health in young, naturally cycling women. Participants will take the medication and have their cardiovascular health measured over a short period.
Hamilton, OntarioAges 18–35 - NCT03557619RecruitingPhase 1
Venetoclax test in women with specific non-Hodgkin lymphomas
This Phase 1 study tests how venetoclax affects certain hormone pills (ethinyl estradiol and levonorgestrel) in women with different non-Hodgkin lymphomas. It’s mainly looking at safety and drug interactions, which could help guide treatment for people who need hormone-based contraception.
Detroit, MichiganAges 18 years+ - NCT05044962Recruiting
Study birth control timing in HIV, using blood tests
This study looks at how well HIV treatment (ART) and a hormonal birth control method (DMPA shot or implant) work together, using small blood samples. It may help ensure safer, more effective HIV care and contraception for young women.
Eldoret, KenyaAges 15–24 - NCT05316493RecruitingPhase 2/Phase 3
Weight-loss and progesterone treatments for early uterine lining disease
This trial studies a weight-management approach plus a progesterone-releasing IUD (LNG-IUS) and megestrol to treat endometrial atypical hyperplasia, a high-risk precancer of the uterine lining. It may help shrink or control the abnormal cells while supporting fertility or keeping the uterus.
ShanghaiAges 18–45 - NCT05903131RecruitingPhase 2
Lifestyle program to help keep the uterus in early cancer
This Phase 2 study tests whether a lifestyle transformation can help treat complex atypical endometrial hyperplasia or early (grade 1) endometrial cancer without removing the uterus. It may help support uterine preservation for people who want to keep fertility or avoid hysterectomy.
St Louis, MissouriAges 18 years+ - NCT05916469Recruiting
Hormone treatment for heavy periods in teens and young adults
This trial studies how a progestin hormone—given as an IUD or tablets—can help reduce heavy menstrual bleeding in people with certain bleeding-related conditions. It may help you by testing whether the treatment works and is practical for your situation.
Palo Alto, CaliforniaAges 10–24 - NCT07107334RecruitingPhase 2
GLP-1 drug plus hormone IUD for early endometrial cancer in obesity
This trial tests if adding a GLP-1 weight-loss drug to a hormone-releasing IUD can help treat very early endometrial cancer or a precancerous condition in women with obesity. The goal is to see if this combination is effective without surgery.
Gainesville, FloridaAges 18 years+
What Levonorgestrel is being studied for
Conditions with recruiting Levonorgestrel studies.
Common questions
- Are there clinical trials studying Levonorgestrel?
- Yes. Clin2 currently lists 12 recruiting studies that include Levonorgestrel, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Levonorgestrel trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Levonorgestrel an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Levonorgestrel or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.